Update on TB Vaccine Pipeline
Open Access
- 9 April 2020
- journal article
- review article
- Published by MDPI AG in Applied Sciences
- Vol. 10 (7), 2632
- https://doi.org/10.3390/app10072632
Abstract
In addition to antibiotics, vaccination is considered among the most efficacious methods in the control and the potential eradication of infectious diseases. New safe and effective vaccines against tuberculosis (TB) could be a very important tool and are called to play a significant role in the fight against TB resistant to antimicrobials. Despite the extended use of the current TB vaccine Bacillus Calmette-Guérin (BCG), TB continues to be transmitted actively and continues to be one of the 10 most important causes of death in the world. In the last 20 years, different TB vaccines have entered clinical trials. In this paper, we review the current use of BCG and the diversity of vaccines in clinical trials and their possible indications. New TB vaccines capable of protecting against respiratory forms of the disease caused by sensitive or resistant Mycobacterium tuberculosis strains would be extremely useful tools helping to prevent the emergence of multi-drug resistance.Keywords
Funding Information
- EDCTP (RIA2016V-1637.)
- Ministry of Science Spain (RTI2018-097625-B-I00)
This publication has 71 references indexed in Scilit:
- A small jab – a big effect: nonspecific immunomodulation by vaccinesTrends in Immunology, 2013
- Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCGTuberculosis, 2013
- Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trialVaccine, 2013
- Bacille Calmette-Guérin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytesProceedings of the National Academy of Sciences, 2012
- Risk of Progression to Active Tuberculosis Following Reinfection With Mycobacterium tuberculosisClinical Infectious Diseases, 2012
- The BCG World Atlas: A Database of Global BCG Vaccination Policies and PracticesPLoS Medicine, 2011
- Report of an international collaborative study to evaluate the suitability of multiplex PCR as an identity assay for different sub-strains of BCG vaccineVaccine, 2010
- WHO Informal Consultation on standardization and evaluation of BCG vaccines Geneva, Switzerland 22–23 September 2009Vaccine, 2010
- Genome plasticity of BCG and impact on vaccine efficacyProceedings of the National Academy of Sciences, 2007
- Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysinJCI Insight, 2005